Lancor Scientific The ICO Project

Upcoming ICO List Ongoing ICO List Closed ICO List

Project Overview Updated:

Project name

Lancor Scientific

Ticker ( Symbol )


Timeline ( UTC )


Target / Supply Amount

20,000,000 USD
450,000,000 MEDICI


Lancor Scientific will provide global access to life-saving cancer screening. Current cancer screening tests are often expensive, inaccurate, slow and dangerous. Lancor Scientific uses a patented light technology to detect the change of electromagnetism in tissue. It will be able to test for all cancers. Lancor Scientific's Medici Token allows payment for tests at any clinic using the Lancor Blockchain Platform (LBP), and provides secure access to results. The earlier we find cancer, the more lives we save.

Team Members

Aamir Butt : CEO
Prof. Roland Schlesinger MD : Chief Medical Officer
Prof. Paul Darbyshire : CTO
Stephen Pigney : CFO
Gopal Rao : COO
Robert Elding : CMO
Prof. Adenike Grange MBChB : Ambassador, Africa Region
Ryan Lavelle : Head of Product Delivery
Nick Holmes : SVP Engineering and Design
Rory Lavelle : Sales Director
Victoria Gavaza : Regional Director, Africa
Lauren Sterling : Operations Manager
Dr Khalil Razvi, MB BCh : Special Advisor
Professor Dr. A Min Tjoa : Special Advisor
Julian Burn-Callander : Compliance Consultant
Gary Nuttall : Special Advisor
James Barrington-Brown : Special Advisor
David Janczewski : Special Advisor
Siam Kidd : Special Advisor

Token Platform


Country Base

United Kingdom

Social Activities

  • Because there may be time differences in information updates, accurate information about each ICO project should be verified through its official website or other communication channels.
  • This information is not a suggestion or advice on investing in ICO funding. Please thoroughly investigate the relevant information yourself and decide on ICO participation.
  • If you think there are issues or problems to be corrected on this content, or if you would like to submit your own ICO project to be listed, Please email us